{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:01:44Z","timestamp":1782212504476,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This study aimed to evaluate the predictive performance of an artificial intelligence (AI)-based algorithm in estimating the risk of cardio-cerebrovascular complications in patients with type 2 diabetes mellitus (T2D).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Medical records of 532 T2D patients from the Diabetology Unit in Padova, Italy, were analyzed using the Metaclinic AI Prediction Module, which estimates the probability of heart and cerebrovascular organ damage. For patients identified as \u201cVery high\u201d (<jats:italic>n<\/jats:italic>\u2009=\u200963) or \u201cLow\u201d (<jats:italic>n<\/jats:italic>\u2009=\u2009122) risk for heart disease, additional clinical and instrumental data on their cardiac history were collected. The level of agreement between AI predictions and traditional clinical-instrumental diagnostics was assessed using Cohen\u2019s \u03ba coefficient.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In the \u201cVery high\u201d risk group, the agreement between AI predictions and clinical diagnostics for heart disease was poor (\u03ba\u2009=\u20090.00), while prediction for cerebrovascular disease showed excellent agreement (\u03ba\u2009=\u20090.89). Similarly, in the \u201cLow\u201d risk group, agreement for heart disease remained poor (\u03ba\u2009=\u20090.00), but agreement for cerebrovascular disease was again high (\u03ba\u2009=\u20090.83).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>A marked difference was observed in the algorithm\u2019s performance. While the AI showed strong predictive ability for cerebrovascular complications, it failed to reliably predict heart disease risk. These results suggest that the algorithm may be clinically valuable for cerebrovascular risk assessment but needs refinement for cardiac prediction.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13098-025-01910-6","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:19:22Z","timestamp":1756282762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Artificial intelligence algorithm for predicting cardio-cerebrovascular risk in type 2 diabetes: concordance with clinical and instrumental assessments"],"prefix":"10.1186","volume":"17","author":[{"given":"Francesco","family":"Piarulli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Ragazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Celeste","family":"Celsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annunziata","family":"Lapolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Sartore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"issue":"1","key":"1910_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","volume":"9","author":"X Lu","year":"2024","unstructured":"Lu X, Xie Q, Pan X, et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther. 2024;9(1):262. https:\/\/doi.org\/10.1038\/s41392-024-01951-9.","journal-title":"Signal Transduct Target Ther"},{"key":"1910_CR2","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes care. 2025;48(1 Suppl 1):S27\u2013S49. https:\/\/doi.org\/10.2337\/dc25-S002","DOI":"10.2337\/dc25-S002"},{"issue":"6865","key":"1910_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813\u201320. https:\/\/doi.org\/10.1038\/414813a.","journal-title":"Nature"},{"issue":"8","key":"1910_CR4","doi-asserted-by":"publisher","first-page":"6651","DOI":"10.3390\/cimb45080420","volume":"45","author":"A Caturano","year":"2023","unstructured":"Caturano A, D\u2019Angelo M, Mormone A, et al. Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications. Curr Issues Mol Biol. 2023;45(8):6651\u201366. https:\/\/doi.org\/10.3390\/cimb45080420.","journal-title":"Curr Issues Mol Biol"},{"key":"1910_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2022.03.019","volume":"184","author":"JS Bhatti","year":"2022","unstructured":"Bhatti JS, Sehrawat A, Mishra J, et al. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives. Free Radic Biol Med. 2022;184:114\u201334. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.03.019.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1910_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12551-024-01188-4","volume":"16","author":"AB Uceda","year":"2024","unstructured":"Uceda AB, Mari\u00f1o L, Casasnovas R, Adrover M. An overview on glycation: molecular mechanisms, impact on proteins, pathogenesis, and Inhibition. Biophys Rev. 2024;16(2):189\u2013218. https:\/\/doi.org\/10.1007\/s12551-024-01188-4.","journal-title":"Biophys Rev"},{"issue":"8","key":"1910_CR7","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3390\/antiox11081501","volume":"11","author":"F Piarulli","year":"2022","unstructured":"Piarulli F, Banfi C, Brioschi M, et al. The burden of impaired serum albumin antioxidant properties and Glyco-Oxidation in coronary heart disease patients with and without type 2 diabetes mellitus. Antioxid (Basel). 2022;11(8):1501. https:\/\/doi.org\/10.3390\/antiox11081501.","journal-title":"Antioxid (Basel)"},{"issue":"24","key":"1910_CR8","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","volume":"133","author":"CC Low Wang","year":"2016","unstructured":"Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes Mellitus - Mechanisms, management, and clinical considerations. Circulation. 2016;133(24):2459\u2013502. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022194.","journal-title":"Circulation"},{"issue":"8","key":"1910_CR9","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.2337\/diacare.27.8.1954","volume":"27","author":"FJ Wackers","year":"2004","unstructured":"Wackers FJ, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27(8):1954\u201361. https:\/\/doi.org\/10.2337\/diacare.27.8.1954.","journal-title":"Diabetes Care"},{"issue":"4","key":"1910_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229\u201334. https:\/\/doi.org\/10.1056\/NEJM199807233390404.","journal-title":"N Engl J Med"},{"issue":"11","key":"1910_CR11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/ncpcardio1344","volume":"5","author":"M Laakso","year":"2008","unstructured":"Laakso M. Diabetes as a \u2018cardiovascular disease equivalent\u2019: implications for treatment. Nat Clin Pract Cardiovasc Med. 2008;5(11):682\u20133. https:\/\/doi.org\/10.1038\/ncpcardio1344.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"2suppl","key":"1910_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2047487319878371","volume":"26","author":"E Dal Canto","year":"2019","unstructured":"Dal Canto E, Ceriello A, Ryd\u00e9n L, et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26(2suppl):25\u201332. https:\/\/doi.org\/10.1177\/2047487319878371.","journal-title":"Eur J Prev Cardiol"},{"issue":"39","key":"1910_CR13","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043\u2013140. https:\/\/doi.org\/10.1093\/eurheartj\/ehad192.","journal-title":"Eur Heart J"},{"issue":"9","key":"1910_CR14","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1161\/STROKEAHA.107.511584","volume":"39","author":"P Prati","year":"2008","unstructured":"Prati P, Tosetto A, Vanuzzo D, et al. Carotid intima media thickness and plaques can predict the occurrence of ischemic cerebrovascular events. Stroke. 2008;39(9):2470\u20136. https:\/\/doi.org\/10.1161\/STROKEAHA.107.511584.","journal-title":"Stroke"},{"key":"1910_CR15","doi-asserted-by":"publisher","unstructured":"Touboul PJ, Hennerici MG, Meairs S et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290\u2013296. https:\/\/doi.org\/10.1159\/000343145","DOI":"10.1159\/000343145"},{"issue":"6","key":"1910_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1042\/cs1010671","volume":"101","author":"RJ Stevens","year":"2001","unstructured":"Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond). 2001;101(6):671\u20139.","journal-title":"Clin Sci (Lond)"},{"issue":"28","key":"1910_CR17","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1093\/eurheartj\/ehad260","volume":"44","author":"SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration","year":"2023","unstructured":"SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration. SCORE2-Diabetes: 10-year cardiovascular risk Estimation in type 2 diabetes in Europe. Eur Heart J. 2023;44(28):2544\u201356. https:\/\/doi.org\/10.1093\/eurheartj\/ehad260.","journal-title":"Eur Heart J"},{"key":"1910_CR18","unstructured":"METEDA S.r.l. MetaClinic User Guide: AI Prediction Module, version rev.01, METEDA S.r.l., Rome, Italy, 2023."},{"key":"1910_CR19","doi-asserted-by":"publisher","first-page":"110013","DOI":"10.1016\/j.diabres.2022.110013","volume":"190","author":"A Nicolucci","year":"2022","unstructured":"Nicolucci A, Romeo L, Bernardini M, et al. Prediction of complications of type 2 diabetes: A machine learning approach. Diabetes Res Clin Pract. 2022;190:110013. https:\/\/doi.org\/10.1016\/j.diabres.2022.110013.","journal-title":"Diabetes Res Clin Pract"},{"key":"1910_CR20","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: A scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (KDD \u201916); ACM: New York, NY, USA, 2016; pp. 785\u2013794.","DOI":"10.1145\/2939672.2939785"},{"key":"1910_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37\u201346.","journal-title":"Educ Psychol Meas"},{"issue":"1","key":"1910_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u201374.","journal-title":"Biometrics"},{"issue":"6","key":"1910_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/0895-4356(90)90158-1","volume":"43","author":"AR Feinstein","year":"1990","unstructured":"Feinstein AR, Cicchetti DV. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol. 1990;43(6):543\u20139. https:\/\/doi.org\/10.1016\/0895-4356(90)90158-1.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"1910_CR24","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/biomedicines13051075","volume":"13","author":"G Sartore","year":"2025","unstructured":"Sartore G, Ragazzi E, Pegoraro F, Pagno MG, Lapolla A, Piarulli F. Artificial intelligence algorithm to screen for diabetic neuropathy: A pilot study. Biomedicines. 2025;13(5):1075. https:\/\/doi.org\/10.3390\/biomedicines13051075.","journal-title":"Biomedicines"},{"key":"1910_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12933-023-01741-7","volume":"22","author":"OT Kee","year":"2023","unstructured":"Kee OT, Harun H, Mustafa N, et al. Cardiovascular complications in a diabetes prediction model using machine learning: a systematic review. Cardiovasc Diabetol. 2023;22:13. https:\/\/doi.org\/10.1186\/s12933-023-01741-7.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1910_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12933-023-01985-3","volume":"22","author":"EK Oikonomou","year":"2023","unstructured":"Oikonomou EK, Khera R. Machine learning in precision diabetes care and cardiovascular risk prediction. Cardiovasc Diabetol. 2023;22(1):259. https:\/\/doi.org\/10.1186\/s12933-023-01985-3.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"1910_CR27","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41591-020-0870-z","volume":"26","author":"S Raghunath","year":"2020","unstructured":"Raghunath S, Ulloa Cerna AE, Jing L, et al. Prediction of mortality from 12-lead electrocardiogram voltage data using a deep neural network. Nat Med. 2020;26(6):886\u201391. https:\/\/doi.org\/10.1038\/s41591-020-0870-z.","journal-title":"Nat Med"},{"issue":"Suppl 1","key":"1910_CR28","doi-asserted-by":"publisher","first-page":"e70017","DOI":"10.1111\/eci.70017","volume":"55","author":"Y Wang","year":"2025","unstructured":"Wang Y, Aivalioti E, Stamatelopoulos K, et al. Machine learning in cardiovascular risk assessment: towards a precision medicine approach. Eur J Clin Invest. 2025;55(Suppl 1):e70017. https:\/\/doi.org\/10.1111\/eci.70017.","journal-title":"Eur J Clin Invest"},{"key":"1910_CR29","doi-asserted-by":"publisher","first-page":"100072","DOI":"10.1016\/j.ibmed.2022.100072","volume":"6","author":"M Wang","year":"2022","unstructured":"Wang M, Francis F, Kunz H, et al. Artificial intelligence models for predicting cardiovascular diseases in people with type 2 diabetes: A systematic review. Intelligence-Based Med. 2022;6:100072. https:\/\/doi.org\/10.1016\/j.ibmed.2022.100072.","journal-title":"Intelligence-Based Med"},{"issue":"4","key":"1910_CR30","doi-asserted-by":"publisher","first-page":"e0174944","DOI":"10.1371\/journal.pone.0174944","volume":"12","author":"SF Weng","year":"2017","unstructured":"Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N. Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLoS ONE. 2017;12(4):e0174944. https:\/\/doi.org\/10.1371\/journal.pone.0174944.","journal-title":"PLoS ONE"},{"issue":"12","key":"1910_CR31","doi-asserted-by":"publisher","first-page":"e0243558","DOI":"10.1371\/journal.pone.0243558","volume":"15","author":"M Bergamini","year":"2020","unstructured":"Bergamini M, Iora PH, Rocha TAH, et al. Mapping risk of ischemic heart disease using machine learning in a Brazilian state. PLoS ONE. 2020;15(12):e0243558. https:\/\/doi.org\/10.1371\/journal.pone.0243558.","journal-title":"PLoS ONE"},{"issue":"1","key":"1910_CR32","doi-asserted-by":"publisher","first-page":"14966","DOI":"10.1038\/s41598-024-63798-y","volume":"14","author":"H Sang","year":"2024","unstructured":"Sang H, Lee H, Lee M, et al. Prediction model for cardiovascular disease in patients with diabetes using machine learning derived and validated in two independent Korean cohorts. Sci Rep. 2024;14(1):14966. https:\/\/doi.org\/10.1038\/s41598-024-63798-y.","journal-title":"Sci Rep"},{"key":"1910_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/jmms12010014","volume":"12","author":"TG Alexescu","year":"2025","unstructured":"Alexescu TG, Nechita A, Alexander P, et al. Electrocardiographic changes in patients with type 2 diabetes Mellitus\u2014A Meta-Analysis. J Mind Med Sci. 2025;12:14. https:\/\/doi.org\/10.3390\/jmms12010014.","journal-title":"J Mind Med Sci"},{"issue":"3","key":"1910_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12471-020-01515-w","volume":"29","author":"M Lobeek","year":"2021","unstructured":"Lobeek M, Badings E, Lenssen M, et al. Diagnostic value of the electrocardiogram in the assessment of prior myocardial infarction. Neth Heart J. 2021;29(3):142\u201350. https:\/\/doi.org\/10.1007\/s12471-020-01515-w.","journal-title":"Neth Heart J"},{"issue":"4","key":"1910_CR35","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4093\/dmj.2023.0036","volume":"47","author":"SH Lee","year":"2023","unstructured":"Lee SH, Park JH. The role of echocardiography in evaluating cardiovascular diseases in patients with diabetes mellitus. Diabetes Metab J. 2023;47(4):470\u201383. https:\/\/doi.org\/10.4093\/dmj.2023.0036.","journal-title":"Diabetes Metab J"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01910-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01910-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01910-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:54:46Z","timestamp":1757444086000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01910-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01910-6","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and was approved by the Ethics Committee for Clinical Trials in the Province of Padova (study No. 3884\/U16\/16, protocol No. 0045112, approved on 14.07.2016). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"361"}}